• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Amira Pharmaceuticals

edit

Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Their discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.

Recent Milestones

edit

• 
  Amira Pharmaceuticals was acquired by Bristol-Myers Squibb for $325M. (7/21/11)
  Posted 7/22/11 at 5:19am via businesswire.com

Videos

Screenshots

edit

Above: Amira Pharmaceuticals
Uploaded: 7/22/11

Sources

1. Bristol-Myers Squibb to Acquire Amira Pharmaceuticals (businesswire.com) [edit]